797 related articles for article (PubMed ID: 15062159)
1. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Stone NN; Hong S; Lo YC; Howard V; Stock RG
Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
[TBL] [Abstract][Full Text] [Related]
2. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
3. Correlation between real-time intraoperative and postoperative dosimetry and its implications on intraoperative planning.
Yan C; Huq MS; Heron DE; Beriwal S; Wynn RB
Brachytherapy; 2019; 18(3):338-347. PubMed ID: 30655047
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A
Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425
[TBL] [Abstract][Full Text] [Related]
5. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy.
Nag S; Shi P; Liu B; Gupta N; Bahnson RR; Wang JZ
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):311-7. PubMed ID: 17996395
[TBL] [Abstract][Full Text] [Related]
6. Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125.
Shirvani SM; Kudchadker RJ; Bruno TL; Likhacheva A; Swanson DA; Frank SJ
Brachytherapy; 2011; 10(4):269-74. PubMed ID: 21296031
[TBL] [Abstract][Full Text] [Related]
7. Postimplant rectal dosimetry is not dependent on 103Pd or 125I seed activity.
Merrick GS; Sylvester J; Grimm P; Allen ZA; Butler WM; Reed JL; Khanjian J
Brachytherapy; 2011; 10(1):35-43. PubMed ID: 20153264
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative dosimetric representation of the real-time ultrasound-guided prostate implant.
Stock RG; Stone NN; Lo YC
Tech Urol; 2000 Jun; 6(2):95-8. PubMed ID: 10798807
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative Registered Ultrasound and Fluoroscopy (iRUF) for dose calculation during prostate brachytherapy: Improved accuracy compared to standard ultrasound-based dosimetry.
Lee J; Mian OY; Le Y; Bae HJ; Burdette EC; DeWeese TL; Prince JL; Song DY
Radiother Oncol; 2017 Jul; 124(1):61-67. PubMed ID: 28647400
[TBL] [Abstract][Full Text] [Related]
10. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy.
Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E
Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606
[TBL] [Abstract][Full Text] [Related]
11. Is intraoperative nomogram-based overplanning of prostate implants necessary?
D'Souza WD; Lee HK; Palmer MB; Smith LG; Pollack A
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):462-7. PubMed ID: 12738321
[TBL] [Abstract][Full Text] [Related]
12. [Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy].
Herein A; Ágoston P; Szabó Z; Jorgo K; Markgruber B; Pesznyák C; Polgár C; Major T
Magy Onkol; 2015 Jun; 59(2):148-53. PubMed ID: 26035163
[TBL] [Abstract][Full Text] [Related]
13. Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
Merrick GS; Butler WM; Wallner KE; Blasko JC; Michalski J; Aronowitz J; Grimm P; Moran BJ; McLaughlin PW; Usher J; Lief JH; Allen ZA
Brachytherapy; 2005; 4(4):241-51. PubMed ID: 16344253
[TBL] [Abstract][Full Text] [Related]
14. Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted images.
Ohashi T; Momma T; Yamashita S; Nagatsuma K; Kanai K; Kitagawa K; Takahashi S; Hanada T; Yorozu A; Shigematsu N
Brachytherapy; 2012; 11(6):468-75. PubMed ID: 22330102
[TBL] [Abstract][Full Text] [Related]
15. Difference in rectal dosimetry between pre-plan and post-implant analysis in transperineal interstitial brachytherapy for prostate cancer.
Ishiyama H; Kitano M; Satoh T; Niibe Y; Uemae M; Fujita T; Baba S; Hayakawa K
Radiother Oncol; 2006 Feb; 78(2):194-8. PubMed ID: 16414135
[TBL] [Abstract][Full Text] [Related]
16. Planning based on postneedle volume with early dosimetric assessment is beneficial for Cesium-131 permanent prostate seed implantation.
Smith RP; Beriwal S; Komanduri K; Gibbons E; Benoit R
Brachytherapy; 2008; 7(3):237-41. PubMed ID: 18599357
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy.
Bowes D; Crook JM; Araujo C; Batchelar D
Brachytherapy; 2013; 12(1):38-43. PubMed ID: 22727473
[TBL] [Abstract][Full Text] [Related]
18. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
Merrick GS; Butler WM; Dorsey AT; Lief JH
Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
[TBL] [Abstract][Full Text] [Related]
19. Poor predictive value of intraoperative real-time dosimetry for prostate seed brachytherapy.
Igidbashian L; Donath D; Carrier JF; Lassalle S; Hervieux Y; David S; Bahary JP; Taussky D
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):605-9. PubMed ID: 18793964
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of intraoperative dosimetry for prostate brachytherapy using registered ultrasound and fluoroscopy.
Lee J; Hobbs RF; Zahurak M; Ng SK; Zhang Z; Burdette EC; DeWeese TL; Song DY
Brachytherapy; 2018; 17(6):858-865. PubMed ID: 30217432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]